EUVIMEDEUVIMED entdecken
Crossref

Anemia Biomarkers in Pregnant People with Pyelonephritis

Noor K Al-Shibli, Kristin E Weaver, Matthew R Grace, Jeffrey A Kuller, R Phillips Heine, Shakthi Unnithan, Sarah K Dotters-Katz

American Journal of Perinatology · 01.10.2025 · 42 (14) · 1871-1874

DOI: 10.1055/a-2547-4135 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Perinatology, erschienen am 01.10.2025. Verfasst von Noor K Al-Shibli und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Duke University, Durham, North Carolina. Hauptthemen laut MEDLINE: Pyelonephritis, Erythropoietin, Anemia, Pregnancy Complications, Hematologic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 16 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Anemia is observed in 30% of pregnancies with pyelonephritis, yet little is known about the underlying etiology. Erythropoietin (EPO) is renally produced in response to hypoxic and inflammatory conditions. Changes in serum EPO have been demonstrated in infectious conditions in the nonpregnant population. EPO levels have been measured in healthy pregnancy cohorts, but little is known about patterns in the setting of renal inflammation. Our primary objective was to compare EPO levels in pregnant patients at diagnosis of acute pyelonephritis to established trimester-specific norms. Secondary objectives included assessing iron deficiency and hemolysis markers as alternate etiologies of anemia. Prospective cohort study of pregnant people aged ≥ 18 years diagnosed with pyelonephritis, defined as the presence of urinary tract infection symptoms plus flank pain, fever, or nausea/vomiting. Blood samples including EPO, iron, transferrin, lactate dehydrogenase (LDH), and haptoglobin were obtained within 72 hours of diagnosis. Demographics and clinical data were abstracted from medical records. Wilcoxon Signed-Rank test compared study EPO levels to noninfected pregnancy values established in the literature. Secondary outcomes included number of patients with iron/hemolysis laboratories within trimester-specific reference ranges. The study cohort included 17 patients with pyelonephritis in the second or third-trimester. There were no eligible first-trimester patients during the study period. Anemia was present on admission in 35.3% (6/17) of patients. EPO levels were significantly higher in pyelonephritis patients during the second-trimester compared with literature-established EPO levels in noninfected controls: 48.6 versus 10.6 mU/mL, (p = 0.0001). Secondary analysis demonstrated normal iron and haptoglobin levels in most patients, and normal LDH in all patients. EPO levels in pregnant pyelonephritis patients were significantly higher compared with trimester-specific normative levels established in the literature. Evaluation of iron and hemolysis studies showed inconsistent results but were often normal. This pilot study may suggest a relationship between ineffective erythropoiesis and renal inflammation in pregnancies complicated by pyelonephritis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PyelonephritisErythropoietinAnemiaPregnancy Complications, HematologicHumansFemalePregnancyBiomarkersAdultProspective StudiesHaptoglobinsIronL-Lactate DehydrogenaseTransferrinYoung AdultHemolysisCase-Control Studies

Substanzen

BiomarkersHaptoglobinsErythropoietinIronL-Lactate DehydrogenaseTransferrin

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Duke University, Durham, North Carolina.
  • Department of Gynecology and Obstetrics, Emory University School of Medicine, Atlanta, Georgia.
  • Department of Obstetrics and Gynecology, Vanderbilt University, Nashville, Tennessee.
  • Department of Obstetrics and Gynecology, Wake Forest Baptist Medical Center, Winston-Salem, North Carolina.
  • Department of Biostatistics & Bioinformatics, Duke University School of Medicine, Durham, North Carolina.

Zitieren

APA

Al-Shibli, N. K., Weaver, K. E., Grace, M. R., Kuller, J. A., Heine, R. P., Unnithan, S., & Dotters-Katz, S. K. (2025). Anemia Biomarkers in Pregnant People with Pyelonephritis. American Journal of Perinatology, 42(14), 1871-1874. https://doi.org/10.1055/a-2547-4135

Vancouver

Al-Shibli NK, Weaver KE, Grace MR, Kuller JA, Heine RP, Unnithan S, et al. Anemia Biomarkers in Pregnant People with Pyelonephritis. American Journal of Perinatology. 2025;42(14):1871-1874. doi:10.1055/a-2547-4135

BibTeX
@article{AlShibli2025,
  author = {Al-Shibli, Noor K and Weaver, Kristin E and Grace, Matthew R and Kuller, Jeffrey A and Heine, R Phillips and Unnithan, Shakthi and Dotters-Katz, Sarah K},
  title = {Anemia Biomarkers in Pregnant People with Pyelonephritis},
  journal = {American Journal of Perinatology},
  year = {2025},
  volume = {42},
  number = {14},
  pages = {1871--1874},
  doi = {10.1055/a-2547-4135}
}
Kostenlos starten →